Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

NCT06058988 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer
Glioblastoma
Metastatic Cancer
Leptomeningeal Metastasis
Recurrent Glioblastoma

Interventions

DRUG: Trastuzumab deruxtecan

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]